NDC 55150-431

DACTINOMYCIN

Dactinomycin

DACTINOMYCIN is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Auromedics Pharma Llc. The primary component is Dactinomycin.

Product ID55150-431_aa047ee8-f2e8-4720-84b1-d1c4532d6c63
NDC55150-431
Product TypeHuman Prescription Drug
Proprietary NameDACTINOMYCIN
Generic NameDactinomycin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-03-15
Marketing CategoryANDA /
Application NumberANDA203385
Labeler NameAuroMedics Pharma LLC
Substance NameDACTINOMYCIN
Active Ingredient Strength1 mg/mL
Pharm ClassesActinomycin [EPC], Nucleic Acid Synthesis Inhibitors [MoA], Protein Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 55150-431-01

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-431-01) > 1 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2021-03-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "DACTINOMYCIN" or generic name "Dactinomycin"

NDCBrand NameGeneric Name
39822-2100dactinomycindactinomycin
42658-008Dactinomycindactinomycin
55150-431DACTINOMYCINDACTINOMYCIN
55150-928DACTINOMYCINDACTINOMYCIN
66993-489DactinomycinDactinomycin
67457-513DactinomycinDactinomycin
67457-928DactinomycinDactinomycin
71288-129DactinomycinDactinomycin
55292-811Cosmegendactinomycin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.